Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
MoonLake Immunotherapeutics
MLTX
$1.53B
| $21.1M | ﹤0.01% |
+413,269
| New | +$11.1M |
|
|
SWN
927
DELISTED
Southwestern Energy Company
SWN
| $21.1M | ﹤0.01% |
3,506,037
+3,261,599
| +1,334% | +$16.8M |
|
928
CNB Financial Corp
CCNE
$1.06B
| $21.1M | ﹤0.01% |
1,193,618
-217,651
| -15% | -$3.9M |
|
929
StoneCo
STNE
$2.73B
| $20.8M | ﹤0.01% |
1,630,481
+842,044
| +107% | +$10.5M |
|
930
Interface
TILE
$2.01B
| $20.7M | ﹤0.01% |
2,355,593
+467,329
| +25% | +$3.58M |
|
931
Littelfuse
LFUS
$11.8B
| $20.7M | ﹤0.01% |
71,019
+888
| +1% | +$233K |
|
|
HOLI
932
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $20.6M | ﹤0.01% |
1,172,520
-47,262
| -4% | -$773K |
|
|
HFSI
933
Hartford Strategic Income ETF
HFSI
$1.07B
| $20.6M | ﹤0.01% |
620,000
| – | – |
|
934
O'Reilly Automotive
ORLY
$74.9B
| $20.5M | ﹤0.01% |
322,620
+30,495
| +10% | +$1.86M |
|
|
OLO
935
DELISTED
Olo Inc
OLO
| $20.5M | ﹤0.01% |
3,174,950
-2,304,988
| -42% | -$16.6M |
|
936
Stem
STEM
$53.6M
| $19.9M | ﹤0.01% |
173,873
-40,879
| -19% | -$4.06M |
|
937
Five Below
FIVE
$12.3B
| $19.7M | ﹤0.01% |
100,406
-42,976
| -30% | -$8.4M |
|
|
NXGN
938
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $19.6M | ﹤0.01% |
1,209,244
+224,930
| +23% | +$3.73M |
|
939
Argan
AGX
$8.66B
| $19.5M | ﹤0.01% |
494,135
+279,435
| +130% | +$11.3M |
|
940
Franco-Nevada
FNV
$42.2B
| $19.5M | ﹤0.01% |
136,400
-17,096
| -11% | -$2.56M |
|
941
Nokia
NOK
$55.4B
| $19.4M | ﹤0.01% |
4,663,441
+14,378
| +0.3% | +$60.8K |
|
942
Baidu
BIDU
$38.2B
| $19.3M | ﹤0.01% |
141,268
-85,618
| -38% | -$11.2M |
|
943
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $19.3M | ﹤0.01% |
418,569
-144,229
| -26% | -$6.63M |
|
944
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $19.2M | ﹤0.01% |
221,679
-93,316
| -30% | -$7.97M |
|
945
Vesta Real Estate
VTMX
$3.17B
| $19M | ﹤0.01% |
+590,778
| New | +$19M |
|
|
RPT
946
Rithm Property Trust
RPT
$93.4M
| $19M | ﹤0.01% |
517,309
-122,193
| -19% | -$4.39M |
|
|
LADR
947
Ladder Capital
LADR
$1.22B
| $18.9M | ﹤0.01% |
1,745,334
-233,976
| -12% | -$2.27M |
|
948
Ryder
R
$10.3B
| $18.8M | ﹤0.01% |
221,679
+213,701
| +2,679% | +$17.6M |
|
949
UFP Technologies
UFPT
$2.59B
| $18.5M | ﹤0.01% |
95,684
-113,932
| -54% | -$17.6M |
|
950
Antero Midstream
AM
$10.4B
| $18.5M | ﹤0.01% |
1,591,305
-15,273
| -1% | -$162K |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.